Magic Mushrooms Expand the Mind By Dampening Brain Activity
- More than half a century ago, author Aldous Huxley titled his book on his experience with hallucinogens The Doors of Perception, borrowing a phrase from a 1790 William Blake poem (which, yes, also lent Jim Morrison’s band its moniker).
If the doors of perception were cleansed, every thing
would appear to man as it is, infinite. For man has closed himself up,
till he sees all things through narrow chinks of his cavern.
- Based on this idea, Huxley posited that ordinary consciousness
represents only a fraction of what the mind can take in. In order to
keep us focused on survival, Huxley claimed, the brain must act as a
“reducing valve” on the flood of potentially overwhelming sights,
sounds and sensations. What remains, Huxley wrote, is a “measly trickle
of the kind of consciousness” necessary to “help us to stay alive.”
- A new study
by British researchers supports this theory. It shows for the first
time how psilocybin — the drug contained in magic mushrooms — affects
the connectivity of the brain. Researchers found that the psychedelic
chemical, which is known to trigger feelings of oneness with the
universe and a trippy hyperconsciousness, does not work by ramping up
the brain’s activity as they’d expected. Instead, it reduces it.
- Under the influence of mushrooms, overall brain activity drops,
particularly in certain regions that are densely connected to sensory
areas of the brain. When functioning normally, these connective “hubs”
appear to help constrain the way we see, hear and experience the world,
grounding us in reality. They are also the key nodes of a brain network
linked to self-consciousness and depression. Psilocybin cuts activity
in these nodes and severs their connection to other brain areas,
allowing the senses to run free.
- “The results seem to imply that a lot of brain activity is actually
dedicated to keeping the world very stable and ordinary and familiar
and unsurprising,” says Robin Carhart-Harris, a postdoctoral student at
Imperial College London and lead author of the study published in Proceedings of the National Academy of Sciences.
- Indeed, Huxley and Blake had predicted what turns out to be a key
finding of modern neuroscience: many of the human brain’s highest
achievements involve preventing actions instead of initiating them, and
sifting out useless information rather than collecting and presenting
it for conscious consideration.
- For the study, the authors recruited 15 brave volunteers to receive
injections of psilocybin or placebo, in alternate sessions, while being
scanned in an fMRI machine. Taken intravenously, psilocybin alters
consciousness in a mere 60 seconds, as opposed to the 40 minutes it
normally takes when administered orally. And the high lasts a half an
hour, not the five hours that typical users experience.
- Provisions were made for the possibility that the participants might
panic while high in the noisy, claustrophic setting of the scanner, but
none of the volunteers did so. In fact, once they’d become accustomed
to the noise and small space, “they quite liked being enclosed and felt
secure,” Carhart-Harris says. All of the participants had previously
been, as Jimi Hendrix put it, “experienced.”
- Researchers had assumed that the hallucinations and bizarre
sensations caused by psilocybin would have at least one part of the
brain working overtime. But instead they found the opposite.
- “The decline in activity was the most surprising finding,” says
Carhart-Harris, “and anything that’s of surprise is usually important.”
- Reducing the brain’s activity interfered with its normal ability to
filter out stimuli, allowing participants to see afresh what would
ordinarily have been dismissed as irrelevant or as background noise.
They described having wandering thoughts, dreamlike perceptions,
geometric visual hallucinations and other unusual changes in their
sensory experiences, like sounds triggering visual images.
- Indeed, if we always paid attention to every perceptible sensation
or impulse like this, we’d be incapable of focusing at all. This is why
it’s difficult to sit still and try to tune in all the feelings and
perceptions we normally tune out, but why also, like psychedelic drugs,
meditation can make the world seem strange and new.
- The particular brain regions that were silenced or disconnected from
each other by the drug also provided insight on the nature of
psychedelic experience and the therapeutic potential of psilocybin. Two
regions that showed the greatest decline in activity were the medial
prefrontal cortex (mPFC) and the posterior cingulate cortex (PCC).
- The mPFC is an area that, when dysfunctional, is linked with
rumination and obsessive thinking. “Probably the most reliable finding
in depression is that the mPFC is overactive,” says Carhart-Harris.
- All antidepressant treatments studied so far — from Prozac,
ketamine, electroconvulsive therapy and talk therapy to placebo —
reduce activity in the mPFC when they are effective. Since psilocybin
does the same, Carhart-Harris and his colleagues plan to study it as a
treatment for depression. “It shuts off this ruminating area and allows
the mind to work more freely,” he says. “That’s a strong indication of
the potential of psilocybin as a treatment for depression.”
- The PCC is thought to play a key role in consciousness and
self-identity. “The most intriguing aspect was that the decreases in
activity were in specific regions that belong to a network in the brain
known as the default network,” notes Carhart-Harris. “There’s a lot of
evidence that it’s associated with our sense of self — our ego or
personality, who we are.”
- “What’s often said about psychedelic experience is that people
experience a temporary dissolution of their ego or sense of being an
independent agent with a particular personality,” he says. “Something
seems to happen where the sense of self dissolves, and that overlaps
with ideas in Eastern philosophy and Buddhism.” This sense of being at
one with the universe, losing one’s “selfish” sense and vantage point,
and feeling the connectedness of all beings often brings profound peace.
- The researchers also looked for an effect on the language-processing
areas of the brain, since users so often report that their experience
is difficult to put into words. “There wasn’t any correlation between
people saying that the experience was ineffable and any change in brain
activity,” Carhart-Harris says. “It may just be because the way we
symbolize the world with language is a constrained function. It has a
degree of precision to it, really, and these drug experiences are so
unusual we don’t have words to describe them.”
- Carhart-Harris and his colleagues did find support for claims made
by sufferers of painful cluster headaches that psilocybin reduces the
frequency of their attacks. These headaches are known to involve
overactivity of a brain area called the hypothalamus, and psilocybin
calmed this region.
- Interestingly, Nature‘s Mo Costandi reports that another study of the effects of psilocybin on the brain found the opposite effect of Carhart-Harris’ group:
“We have completed a number of similar studies and we
always saw an activation of these same areas,” says Franz Vollenweider
at the University of Zurich in Switzerland. “We gave the drug orally
and waited an hour, but they administered it intravenously just before
the scans, so one explanation is that [their] effects were not that
strong.”*
- Another neuroscientist told Nature that some studies find
that lowered activation of the mPFC is associated with anticipatory
anxiety rather than calmness or overall lack of depression. The
researcher theorizes that the brain images in the current study picked
up the participants’ fear, rather than their mystical experiences. But
that conflicts with participants’ reports: they said their trips were
mainly positive.
- Carhart-Harris cautions against using psilocybin outside of a
well-monitored therapeutic setting, however, particularly for patients
with depression. “What we found was in healthy volunteers,” he says.
“They liked the experience and didn’t have negative reactions, but
during depression people are more sensitive to having a negative
response to psychedelic drugs.”
- In fact, that may help explain why psychedelic drugs are rarely addictive and why some of them may even have potential
to treat other addictions. Unlike addictive drugs, which typically
allow users to escape, psychedelic drugs have the opposite effect:
instead of allowing users to avoid negative emotions, they magnify the
painful feelings. Researchers believe this may help patients address
their problems instead of fleeing them — in the context of an
empathetic therapeutic setting — but it can also exacerbate distress.
(Psilocybin is illegal
in the U.S. and is considered a Schedule 1 drug, a class of substances
that “have a high potential for abuse and serve no legitimate medical
purpose in the United States,” according to the Department of Justice.
Other Schedule 1 drugs include marijuana, heroin and LSD.)
- Indeed, the new research bolsters the idea of “psychedelic” as an
accurate label for these drugs. The word was originally coined by
Huxley, from the Greek “psyche” for mind or soul and “delos” for manifest. A
growing body of literature suggests that these drugs can indeed help
scientists understand the workings of the mind and brain, by revealing
some of the underpinnings of consciousness.
- Some have argued, for example, that the geometric visual
hallucinations commonly seen by people on psychedelics (and by some
sufferers of migraines) help reveal the architecture of the brain’s
visual processing mechanism. “One hypothesis is that what you’re
actually seeing is the functional organization of the visual cortex
itself. The visual cortex is organized in a sort of fractal way [it
repeats the same patterns in different sizes]. It’s the same way that
fractals are everywhere in nature. Like tree branches, the brain
recapitulates [itself],” says Carhart-Harris. “You’re not seeing the
cells themselves, but the way they’re organized — as if the brain is
revealing itself to itself.” ~TIME.com
No comments:
Post a Comment